Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Mylafent
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mylafent 100micrograms/hour transdermal patches
0407020A0BUAEAH
|
Mylafent | Fentanyl | Central Nervous System | No data available |
|
Mylafent 12micrograms/hour transdermal patches
0407020A0BUAAAU
|
Mylafent | Fentanyl | Central Nervous System | No data available |
|
Mylafent 25micrograms/hour transdermal patches
0407020A0BUABAE
|
Mylafent | Fentanyl | Central Nervous System | No data available |
|
Mylafent 50micrograms/hour transdermal patches
0407020A0BUACAF
|
Mylafent | Fentanyl | Central Nervous System | No data available |
|
Mylafent 75micrograms/hour transdermal patches
0407020A0BUADAG
|
Mylafent | Fentanyl | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.